Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 3 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Recs

2
Player Avatar cubaislibre (97.56) Submitted: 1/11/2012 6:41:27 PM : Outperform Start Price: $73.89 ALXN Score: +15.24

Cramer's best stock to own for 2012

Featured Broker Partners


Advertisement